![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Saraca Laboratories Limited Gaddapotharam Village In, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Ranitidine hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2004-057 - Rev 08
This Chemical Type CEP, issued on October 20, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 946 associated with this CEP further emphasizes